Pharmacology of paediatric total intravenous anaesthesia

Holford, 1995, The target concentration approach to clinical drug development, Clin Pharmacokinet, 29, 287, 10.2165/00003088-199529050-00001 Benet, 2009, A Holy Grail of clinical pharmacology: prediction of drug pharmacokinetics and pharmacodynamics in the individual patient, Clin Pharmacol Ther, 86, 133, 10.1038/clpt.2009.102 Ma, 2011, Quantitative analysis of continuous intravenous infusions in pediatric anesthesia: safety implications of dead volume, flow rates, and fluid delivery, Paediatr Anaesth, 21, 78, 10.1111/j.1460-9592.2010.03475.x Tsao, 2013, Delivery interaction between co-infused medications: an in vitro modeling study of microinfusion, Paediatr Anaesth, 23, 33, 10.1111/j.1460-9592.2012.03898.x McFarlan, 1999, The use of propofol infusions in paediatric anaesthesia: a practical guide, Paediatr Anaesth, 9, 209 Kataria, 1994, The pharmacokinetics of propofol in children using three different data analysis approaches, Anesthesiology, 80, 104, 10.1097/00000542-199401000-00018 Hill, 1910, The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves, J Physiol, 14, iv Jeleazcov, 2008, Pharmacodynamic modelling of the bispectral index response to propofol-based anaesthesia during general surgery in children, Br J Anaesth, 100, 509, 10.1093/bja/aem408 Roberts, 1988, Induction and maintenance of propofol anaesthesia. A manual infusion scheme, Anaesthesia, 43, 14, 10.1111/j.1365-2044.1988.tb09061.x West, 1999, The fourth dimension of life: fractal geometry and allometric scaling of organisms, Science, 284, 1677, 10.1126/science.284.5420.1677 Anderson, 2008, Mechanism-based concepts of size and maturity in pharmacokinetics, Annu Rev Pharmacol Toxicol, 48, 303, 10.1146/annurev.pharmtox.48.113006.094708 Rigby-Jones, 2007, Remifentanil-midazolam sedation for paediatric patients receiving mechanical ventilation after cardiac surgery, Br J Anaesth, 99, 252, 10.1093/bja/aem135 Ross, 2001, Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures, Anesth Analg, 93, 1393, 10.1097/00000539-200112000-00008 Davis, 1999, The effects of cardiopulmonary bypass on remifentanil kinetics in children undergoing atrial septal defect repair, Anesth Analg, 89, 904, 10.1213/00000539-199910000-00016 Minto, 1997, Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development, Anesthesiology, 86, 10, 10.1097/00000542-199701000-00004 Egan, 1995, Remifentanil pharmacokinetics and pharmacodynamics. A preliminary appraisal, Clin Pharmacokinet, 29, 80, 10.2165/00003088-199529020-00003 Welzing, 2011, Remifentanil degradation in umbilical cord blood of preterm infants, Anesthesiology, 114, 570, 10.1097/ALN.0b013e318204e043 Berde, 1992, Convulsions associated with pediatric regional anesthesia, Anesth Analg, 75, 164, 10.1213/00000539-199208000-00002 Tod, 2008, Facilitation of drug evaluation in children by population methods and modelling, Clin Pharmacokinet, 47, 231, 10.2165/00003088-200847040-00002 Ogawa, 2009, Anesthetic management using total intravenous anesthesia with remifentanil in a child with osteogenesis imperfecta, J Anesth, 23, 123, 10.1007/s00540-008-0698-z Marsh, 1991, Pharmacokinetic model driven infusion of propofol in children, Br J Anaesth, 67, 41, 10.1093/bja/67.1.41 Gepts, 1987, Disposition of propofol administered as constant rate intravenous infusions in humans, Anesth Analg, 66, 1256, 10.1213/00000539-198712000-00010 Absalom, 2003, Accuracy of the ‘Paedfusor’ in children undergoing cardiac surgery or catheterization, Br J Anaesth, 91, 507, 10.1093/bja/aeg220 Rigby-Jones, 2002, Pharmacokinetics of propofol infusions in critically ill neonates, infants, and children in an intensive care unit, Anesthesiology, 97, 1393, 10.1097/00000542-200212000-00010 Minto, 1998, Expanding clinical applications of population pharmacodynamic modelling, Br J Clin Pharmacol, 46, 321, 10.1046/j.1365-2125.1998.00792.x Sepulveda, 2011, Performance evaluation of paediatric propofol pharmacokinetic models in healthy young children, Br J Anaesth, 107, 593, 10.1093/bja/aer198 Rigouzzo, 2010, Pharmacokinetic-pharmacodynamic modeling of propofol in children, Anesthesiology, 113, 343, 10.1097/ALN.0b013e3181e4f4ca Marsh, 2009, Remifentanil in paediatric anaesthetic practice, Anaesthesia, 64, 301, 10.1111/j.1365-2044.2008.05731.x Allegaert, 2007, Maturational pharmacokinetics of single intravenous bolus of propofol, Paediatr Anaesth, 17, 1028, 10.1111/j.1460-9592.2007.02285.x Anderson, 2010, Pediatric models for adult target-controlled infusion pumps, Paediatr Anaesth, 20, 223, 10.1111/j.1460-9592.2009.03072.x Allegaert, 2007, Inter-individual variability in propofol pharmacokinetics in preterm and term neonates, Br J Anaesth, 99, 864, 10.1093/bja/aem294 Steur, 2004, Dosage scheme for propofol in children under 3 years of age, Paediatr Anaesth, 14, 462, 10.1111/j.1460-9592.2004.01238.x Lerman, 2010, Neonatal tracheal intubation: an imbroglio unresolved, Paediatr Anaesth, 20, 585, 10.1111/j.1460-9592.2010.03356.x Bennett, 2009, Practical use of the raw electroencephalogram waveform during general anesthesia: the art and science, Anesth Analg, 109, 539, 10.1213/ane.0b013e3181a9fc38 Davidson, 2006, Measuring anesthesia in children using the EEG, Pediatr Anesth, 16, 374, 10.1111/j.1460-9592.2006.01877.x Davidson, 2005, Performance of entropy and Bispectral Index as measures of anaesthesia effect in children of different ages, Br J Anaesth, 95, 674, 10.1093/bja/aei247 Iwakiri, 2005, Individual effect-site concentrations of propofol are similar at loss of consciousness and at awakening, Anesth Analg, 100, 107, 10.1213/01.ANE.0000139358.15909.EA McCormack, 2010, The effect of a target controlled infusion of propofol on predictability of recovery from anesthesia in children, Paediatr Anaesth, 20, 56, 10.1111/j.1460-9592.2009.03196.x Mani, 2009, Overview of total intravenous anesthesia in children, Paediatr Anaesth, 20, 211, 10.1111/j.1460-9592.2009.03112.x Hume-Smith, 2010, The effect of age on the dose of remifentanil for tracheal intubation in infants and children, Paediatr Anaesth, 20, 19, 10.1111/j.1460-9592.2009.03190.x Long, 2009, Intraoperative opioid dosing in children with and without cerebral palsy, Paediatr Anaesth, 19, 513, 10.1111/j.1460-9592.2009.02980.x Valkenburg, 2009, Lower bispectral index values in children who are intellectually disabled, Anesth Analg, 109, 1428, 10.1213/01ANE.0b013e3181ba43b2 Rigouzzo, 2008, The relationship between bispectral index and propofol during target-controlled infusion anesthesia: a comparative study between children and young adults, Anesth Analg, 106, 1109, 10.1213/ane.0b013e318164f388 Liu, 2007, Closed-loop administration of propofol and remifentanil guided by the Bispectral Index in patient requiring an emergency lung volume reduction, Paediatr Anaesth, 17, 909, 10.1111/j.1460-9592.2007.02303.x Minto, 2003, Using the time of maximum effect site concentration to combine pharmacokinetics and pharmacodynamics, Anesthesiology, 99, 324, 10.1097/00000542-200308000-00014 Billard, 1997, A comparison of spectral edge, delta power, and bispectral index as EEG measures of alfentanil, propofol, and midazolam drug effect, Clin Pharmacol Ther, 61, 45, 10.1016/S0009-9236(97)90181-8 Struys, 2000, Comparison of plasma compartment versus two methods for effect compartment – controlled target-controlled infusion for propofol, Anesthesiology, 92, 399, 10.1097/00000542-200002000-00021 Schnider, 1999, The influence of age on propofol pharmacodynamics, Anesthesiology, 90, 1502, 10.1097/00000542-199906000-00003 Coppens, 2011, An evaluation of using population pharmacokinetic models to estimate pharmacodynamic parameters for propofol and bispectral index in children, Anesthesiology, 115, 83, 10.1097/ALN.0b013e31821a8d80 Hahn, 2011, Two-stage vs mixed-effect approach to pharmacodynamic modeling of propofol in children using state entropy, Paediatr Anaesth, 21, 691, 10.1111/j.1460-9592.2011.03584.x Sneyd, 2007, Effect site: who needs it?, Br J Anaesth, 98, 701, 10.1093/bja/aem106 Rigby-Jones, 2008, Cardiovascular changes after achieving constant effect site concentration of propofol, Anaesthesia, 63, 780, 10.1111/j.1365-2044.2008.05589_1.x Jeleazcov, 2007, EEG variables as measures of arousal during propofol anaesthesia for general surgery in children: rational selection and age dependence, Br J Anaesth, 99, 845, 10.1093/bja/aem275 Munoz, 2009, Prospective evaluation of the time to peak effect of propofol to target the effect site in children, Acta Anaesthesiol Scand, 53, 883, 10.1111/j.1399-6576.2009.01995.x Hahn, 2012, A direct dynamic dose–response model of propofol for individualized anesthesia care, IEEE Trans Biomed Eng, 59, 571, 10.1109/TBME.2011.2177497 Holford, 1992, Population pharmacodynamics and drug development, 401 Anderson, 2012, My child is unique; the pharmacokinetics are universal, Pediatr Anesth, 22, 530, 10.1111/j.1460-9592.2011.03788.x Han, 2007, Dosing in obesity: a simple solution to a big problem, Clin Pharmacol Ther, 82, 505, 10.1038/sj.clpt.6100381 Abernethy, 1986, Drug disposition in obese humans. An update, Clin Pharmacokinet, 11, 199, 10.2165/00003088-198611030-00002 Bouillon, 1998, Does size matter?, Anesthesiology, 89, 557, 10.1097/00000542-199809000-00002 Green, 2004, What is the best size descriptor to use for pharmacokinetic studies in the obese?, Br J Clin Pharmacol, 58, 119, 10.1111/j.1365-2125.2004.02157.x Casati, 2004, Cardiovascular stability during inhalational anaesthesia in morbidly obese patients: which is better, sevoflurane or desflurane?, Br J Anaesth, 93, 153, 10.1093/bja/aeh580 Peters, 2010, Estimated lean body mass is more appropriate than body surface area for scaling glomerular filtration rate and extracellular fluid volume, Nephron Clin Pract, 116, c75, 10.1159/000314666 Olutoye, 2012, The effect of obesity on the ED95 of propofol for loss of consciousness in children and adolescents, Anesth Analg, 115, 147, 10.1213/ANE.0b013e318256858f Green, 2011, Anesthetizing the obese, Anesth Analg, 113, 1, 10.1213/ANE.0b013e318212eae8 McLeay, 2009, Encouraging the move towards predictive population models for the obese using propofol as a motivating example, Pharm Res, 26, 1626, 10.1007/s11095-009-9873-7 Anderson, 2009, Mechanistic basis of using body size and maturation to predict clearance in humans, Drug Metab Pharmacokinet, 24, 25, 10.2133/dmpk.24.25 Rigby-Jones, 2012, Pharmacokinetics and pharmacodynamics – is there anything new?, Anaesthesia, 67, 5, 10.1111/j.1365-2044.2011.06993.x Cortinez, 2010, Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model, Br J Anaesth, 105, 448, 10.1093/bja/aeq195 Schuttler, 2000, Population pharmacokinetics of propofol: a multicenter study, Anesthesiology, 92, 727, 10.1097/00000542-200003000-00017 Diepstraten, 2012, Propofol clearance in morbidly obese children and adolescents: influence of age and body size, Clin Pharmacokinet, 51, 543, 10.1007/BF03261930 Egan, 1998, Remifentanil pharmacokinetics in obese versus lean patients, Anesthesiology, 89, 562, 10.1097/00000542-199809000-00004 Rhodin, 2009, Human renal function maturation: a quantitative description using weight and postmenstrual age, Pediatr Nephrol, 24, 67, 10.1007/s00467-008-0997-5 Mertens, 2004, Mixed-effects modeling of the influence of alfentanil on propofol pharmacokinetics, Anesthesiology, 100, 795, 10.1097/00000542-200404000-00008 Vuyk, 2009, Mixed-effects modeling of the influence of midazolam on propofol pharmacokinetics, Anesth Analg, 108, 1522, 10.1213/ane.0b013e31819e4058 Sumpter, 2011, Phenobarbital and some anesthesia implications, Pediatr Anesth, 21, 995, 10.1111/j.1460-9592.2011.03662.x Herd, 2008, Investigating the pharmacodynamics of ketamine in children, Paediatr Anaesth, 18, 36 Schuttler, 1987, Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man 207–46, 15, 241 Eker, 2011, Children on phenobarbital monotherapy requires more sedatives during MRI, Pediatr Anesth, 21, 998, 10.1111/j.1460-9592.2011.03606.x Minto, 2000, Response surface model for anesthetic drug interactions, Anesthesiology, 92, 1603, 10.1097/00000542-200006000-00017 Park, 2007, Remifentanil halves the EC50 of propofol for successful insertion of the laryngeal mask airway and laryngeal tube in pediatric patients, Anesth Analg, 105, 57, 10.1213/01.ane.0000266447.23037.e4 Standing, 2009, Pharmacokinetic-pharmacodynamic modeling of the hypotensive effect of remifentanil in infants undergoing cranioplasty, Pediatr Anesth, 20, 7, 10.1111/j.1460-9592.2009.03174.x Fujii, 2009, Fentanyl added to propofol anesthesia elongates sinus node recovery time in pediatric patients with paroxysmal supraventricular tachycardia, Anesth Analg, 108, 456, 10.1213/ane.0b013e31819002d4 Allegaert, 2009, Is propofol the perfect hypnotic agent for procedural sedation in neonates?, Curr Clin Pharmacol, 4, 84, 10.2174/157488409788184927 Short, 1994, A prospective evaluation of pharmacokinetic model controlled infusion of propofol in paediatric patients, Br J Anaesth, 72, 302, 10.1093/bja/72.3.302 Murat, 1996, Pharmacokinetics of propofol after a single dose in children aged 1-3 years with minor burns. Comparison of three data analysis approaches, Anesthesiology, 84, 526, 10.1097/00000542-199603000-00006 Saint-Maurice, 1989, Pharmacokinetics of propofol in young children after a single dose, Br J Anaesth, 63, 667, 10.1093/bja/63.6.667